- Country: Brazil
- Summary: Lidocaina 20 Ml, Sertralina 50 Mg, Zolpidem 10mg , Tofacitinibe 5 Mg
- BRT Ref No: 52645740
- Deadline: 04 May 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 422/21
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lidocaine 20 ml, sertraline 50 mg, Zolpidem 10mg, Tofacitinibe 5 mg Executive exposure: 365 days Opening of the session: 05/04/2021 Time: 0900 am
Items composition:
Sequence - Summary Description - Unit of Measurement - Quantity
1 - Lidocaine (hydrochloride) 2% Solution Injectable Bottle-ampoule 20 ml 11100136 501115 - UND - 99675
2 - Sertraline (hydrochloride) 50 mg tablet / capsule 11100109 564117 - UND - 6400380
3 - Zolpidem (hemitarate) 10 mg tablet 11100111 691500 - und - 515060
4 - TOFACITINIB 5 mg Coated tablet (equivalent to 8.078 mg Tofacitinibe Citrate) - und - 3240 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLidocaina 20 Ml, Sertralina 50 Mg, Zolpidem 10mg , Tofacitinibe 5 Mg - Brazil Tender
The HOSP. FAC.DE MED.DA CLINICS, a Government sector organization in Brazil, has announced a new tender for Lidocaina 20 Ml, Sertralina 50 Mg, Zolpidem 10mg , Tofacitinibe 5 Mg. This tender is published on BrazilTenders under BRT Ref No: 52645740 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-05-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
